Literature DB >> 22581145

[Minimally invasive hip arthroplasty - what must be spared?].

M Hoberg1, M Rudert, B Tillmann.   

Abstract

The classical surgical approach to the hip joint has been modified in recent years. The development of minimally invasive surgical techniques promised a particularly gentle soft-tissue preparation with significant benefits in postoperative recovery and intraoperative blood loss for patients undergoing total hip arthroplasty (THA). Exact knowledge of the anatomy of the hip joint and the surrounding structures at risk are essential to avoid complications. Each of the main minimally invasive approaches for THA implicates very specific advantages and disadvantages. Knowing these factors, minimally invasive hip surgery can be performed in a soft tissue-friendly manner. The resulting advantages have to be checked for significant clinical evidence.

Entities:  

Mesh:

Year:  2012        PMID: 22581145     DOI: 10.1007/s00132-011-1888-1

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  23 in total

1.  Modification of the posterolateral approach to the hip for insertion of femoral-head prosthesis.

Authors:  G H MARCY; R S FLETCHER
Journal:  J Bone Joint Surg Am       Date:  1954-01       Impact factor: 5.284

2.  [A posterior mini-incision for total hip arthroplasty -- results of 76 consecutive cases].

Authors:  M Rittmeister; A Peters
Journal:  Z Orthop Ihre Grenzgeb       Date:  2005 Jul-Aug

3.  [Advantages of minimal invasive total hip replacement in the early phase of rehabilitation].

Authors:  D Wohlrab; A Hagel; W Hein
Journal:  Z Orthop Ihre Grenzgeb       Date:  2004 Nov-Dec

4.  Approach to and exposure of the hip joint for mold arthroplasty.

Authors:  M N SMITH-PETERSEN
Journal:  J Bone Joint Surg Am       Date:  1949-01       Impact factor: 5.284

5.  Posterior exposure of the hip joint.

Authors:  A GIBSON
Journal:  J Bone Joint Surg Br       Date:  1950-05

6.  Mini-incision technique for total hip arthroplasty with navigation.

Authors:  Anthony M DiGioia; Anton Y Plakseychuk; Timothy J Levison; Branislav Jaramaz
Journal:  J Arthroplasty       Date:  2003-02       Impact factor: 4.757

7.  The transgluteal approach to the hip joint.

Authors:  R Bauer; F Kerschbaumer; S Poisel; W Oberthaler
Journal:  Arch Orthop Trauma Surg       Date:  1979-10

8.  [The MIS anterolateral approach for THA].

Authors:  H Röttinger
Journal:  Orthopade       Date:  2006-07       Impact factor: 1.087

9.  [Variations in the pathway of the inferior gluteal nerve (author's transl)].

Authors:  B Tillmann
Journal:  Anat Anz       Date:  1979

10.  Minimally invasive uncemented total hip arthroplasty through an anterolateral approach with a shorter skin incision.

Authors:  Fujio Higuchi; Masafumi Gotoh; Noboru Yamaguchi; Ritsu Suzuki; Yoshifumi Kunou; Kazuo Ooishi; Kensei Nagata
Journal:  J Orthop Sci       Date:  2003       Impact factor: 1.601

View more
  3 in total

1.  Comparative retrospective study of the direct anterior and transgluteal approaches for primary total hip arthroplasty.

Authors:  Johannes C Reichert; Maximilian R Volkmann; Maximilian Koppmair; Lars Rackwitz; Martin Lüdemann; Maximilian Rudert; Ulrich Nöth
Journal:  Int Orthop       Date:  2015-03-21       Impact factor: 3.075

2.  A prospective randomized comparison of the minimally invasive direct anterior and the transgluteal approach for primary total hip arthroplasty.

Authors:  Johannes C Reichert; Eberhard von Rottkay; Franz Roth; Tim Renz; Johannes Hausmann; Julius Kranz; Lars Rackwitz; Ulrich Nöth; Maximilian Rudert
Journal:  BMC Musculoskelet Disord       Date:  2018-07-19       Impact factor: 2.362

3.  The Wuerzburg procedure: the tensor fasciae latae perforator is a reliable anatomical landmark to clearly identify the Hueter interval when using the minimally-invasive direct anterior approach to the hip joint.

Authors:  Maximilian Rudert; Konstantin Horas; Maik Hoberg; Andre Steinert; Dominik Emanuel Holzapfel; Stefan Hübner; Boris Michael Holzapfel
Journal:  BMC Musculoskelet Disord       Date:  2016-02-03       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.